Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomasThree cases of hairy cell leukemia in coal miners - letter to editorAcute myeloid leukemia risk by industry and occupationLeukemia among male construction workers in California, 1988- 2007Intensive therapies for mantle cell lymphoma: time for a disease-specific approach?Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?The significance of spliceosome mutations in chronic lymphocytic leukemiaThe evolving treatment paradigm in myelofibrosisTargeting the apoptosis pathway in hematologic malignanciesAsparaginase pharmacokinetics and implications of therapeutic drug monitoringPotential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture CollectionNovel therapies for myelofibrosisDiagnosis of acute basophilic leukemiaHuman Emt tyrosine kinase is specifically expressed both in mature T-lymphocytes and T-cell associated hematopoietic malignanciesCRKL binding to BCR-ABL and BCR-ABL transformationGab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptorsCytogenetic abnormalities in natural killer cell lymphoma/leukaemia--is there a consistent pattern?The major vault protein (MVP), a new multidrug resistance associated protein, is frequently expressed in multiple myelomaCD40 ligand in CLL pathogenesis and therapyStructural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cellsThe anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolismEosinophilic variant of chronic myeloid leukemia with vascular complicationsPrognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaTALE homeoproteins as HOX11-interacting partners in T-cell leukemiaCD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cellsPreferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignanciesThe neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cellsFLT3 and its role in the pathogenesis of acute myeloid leukaemiaDiffuse large cell lymphoma and t(8;22) (q24;q11) in a patient with idiopathic CD4+ T-lymphopeniaCurrent management of polycythemia veraPleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) familyB lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseasesNon-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implicationsIkaros gene expression and leukemiaSurvival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21Expression of G-CSF receptor on myeloid progenitorsInterleukin-6, CD45 and the src-kinases in myeloma cell proliferationTreatment of polycythemia vera and essential thrombocythemia: the role of pipobroman
P1433
Q22305693-11A316D2-0A08-4ABE-8C79-F0FCC9ABA3B3Q23910852-F277901F-8FEC-4EEB-AA05-C261CD131FAAQ23920020-A2263038-8C02-470E-A659-BF351D808A7BQ23921094-698C62AB-802B-4B00-8CB5-8DF40E6F9AE5Q24299054-46474D43-48D7-432B-8B11-954892C9C39BQ24594939-5234859F-2649-4CAA-912C-89A263E73EB9Q26823138-608852DA-195D-41D3-9AE2-6005BECCFBCBQ27021968-FA8D1868-1D5A-4AB2-9D3B-6AB362436322Q27024422-ABB7260B-9952-44A0-A260-AAE1DC64A83DQ27026476-B8CEFEB4-34EF-4174-ACF8-D0B0F80A6965Q27851805-5AFFFB43-D903-4798-BABD-FCE6111E1242Q27853083-563274DA-ABFB-46D2-9FB7-834145C82602Q27913808-E4A794B2-8090-4B40-A588-119079BD9B63Q28081693-7A9E084A-98EC-4B67-8AEB-60812880732FQ28137752-F1F3D25D-88F9-46C3-99A6-197EDFDD5CD4Q28137838-45FC2D33-B3DB-45E9-8375-E4FC26C9A28EQ28140785-351BC43A-5BCB-4705-BB70-B53B733CBA86Q28141018-22FEC2FA-566F-4A5E-9C4B-90CB0B5D3619Q28141563-3B3874BC-1A38-4426-BC8A-06EE826D3CE3Q28141571-C254F96E-5605-4E3D-9C0E-00B2AE8F0276Q28141882-8ACFDF2B-2AA2-4579-B294-6532E3F09F49Q28141885-0674AC4D-44C1-4F75-8FCE-24546D575166Q28165729-0030E9EF-9CE3-499E-8A2F-0E226F9A1839Q28165731-F474B17F-6751-4C3D-943A-7D221FBFFE01Q28186429-8C8601EE-1D45-4D55-A05B-6129F75A853AQ28187803-55B43D49-A9FE-471E-9747-CD22257B435FQ28189946-EE61870C-835B-4A27-A760-0C0C0D187AEAQ28190215-6F8ADE4A-AA23-4043-A8E8-F31F3DCD6386Q28190225-4D010E32-C351-42C1-BFDE-29E9075C4A26Q28190450-42C0B073-F0B3-40CB-A61F-4C5EA845EDBFQ28191129-D55DC384-C2F3-4FB9-B845-9DC42B64C8DEQ28192595-2A01B951-2E30-4204-9AAA-4732668CBB28Q28208696-9ECCC628-4689-4966-BA29-5885460E8ADDQ28208717-A1C40FCA-7BB6-4FD9-AA90-CDD5AC340FECQ28208750-6F2AD1A2-D13D-4EBC-B8EE-EF263C65AC1CQ28208988-CE8AB6F7-2A93-4D90-A882-7DE3FC3A0615Q28209016-ED9249FE-4E15-4594-A3DA-7926FFD44B5BQ28209570-5220C182-69B1-42A8-90F5-58C40D3E7202Q28210841-7A92BC23-FC3C-498D-AE61-9363565DA6F3Q28210858-9FF23E9F-DEB8-44FE-9193-1023599D8BE0
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Leukemia & Lymphoma
@ast
Leukemia & Lymphoma
@da
Leukemia & Lymphoma
@de
Leukemia & Lymphoma
@en
Leukemia & Lymphoma
@es
Leukemia & Lymphoma
@fi
Leukemia & Lymphoma
@fr
Leukemia & Lymphoma
@it
Leukemia & Lymphoma
@nb
Leukemia & Lymphoma
@nl
type
label
Leukemia & Lymphoma
@ast
Leukemia & Lymphoma
@da
Leukemia & Lymphoma
@de
Leukemia & Lymphoma
@en
Leukemia & Lymphoma
@es
Leukemia & Lymphoma
@fi
Leukemia & Lymphoma
@fr
Leukemia & Lymphoma
@it
Leukemia & Lymphoma
@nb
Leukemia & Lymphoma
@nl
altLabel
Leukemia and Lymphoma
@en
prefLabel
Leukemia & Lymphoma
@ast
Leukemia & Lymphoma
@da
Leukemia & Lymphoma
@de
Leukemia & Lymphoma
@en
Leukemia & Lymphoma
@es
Leukemia & Lymphoma
@fi
Leukemia & Lymphoma
@fr
Leukemia & Lymphoma
@it
Leukemia & Lymphoma
@nb
Leukemia & Lymphoma
@nl
P236
P921
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Leuk. Lymphoma
P123
P1250
P1277
P1476
Leukemia & Lymphoma
@en
P236
P243
P3181
P407
P571
1979-01-01T00:00:00Z